Arlington Heights, IL, Aug. 08, 2017 -- The American Society of Plastic Surgeons (ASPS) is proud to welcome Sientra, a leading medical aesthetics company, as a Platinum Level sponsor of Plastic Surgery The Meeting, which takes place October 6 – 10 in Orlando. The premier educational and networking event for board-certified plastic surgeons across the world, Plastic Surgery The Meeting is attended by more than 3,000 plastic surgeons, trainees and other allied health professionals interested in translating the continuing medical education and information they receive into their practices to improve patient care and outcomes.
|
|||
"Sientra has a long-standing commitment to patient safety, product quality and technological innovation,” said Debra Johnson, MD, president of the American Society of Plastic Surgeons. “We value their commitment to working exclusively with board-certified plastic surgeons and appreciate their continued support of the patient safety and enhanced quality-of-life outcomes we advance at Plastic Surgery The Meeting.”
Corporate partners at the Premier Support levels receive unprecedented opportunities to communicate with aesthetic and reconstructive plastic surgeons from around the world. The Platinum Level of support is intended for companies who want to stand apart from their competitors by demonstrating the highest level of commitment to the education of plastic surgeons and advancement of the specialty.
“We are excited to continue our long-standing partnership with ASPS, a society that shares our commitment to the specialty of board-certified plastic surgeons,” said Sientra Chairman and Chief Executive Officer, Jeff Nugent. “As we continue to build a diversified global aesthetics company, we appreciate the opportunities the partnership affords us and is increasingly important in building relationships with key aesthetic and reconstructive plastic surgeons.”
For more information, visit our Plastic Surgery The Meeting website.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including BIOCORNEUM®, the professional choice in scar management, and miraDry, the only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors.
For more information about Sientra, visit www.sientra.com
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0db87659-6991-4653-87a7-8fbf4b9ea857
Adam Ross American Society of Plastic Surgeons 773-332-4719 [email protected]


Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 



